ARIC Publications
Filters: Keyword is Receptor for Advanced Glycation End Products [Clear All Filters]
"Association of plasma levels of soluble receptor for advanced glycation end products and risk of kidney disease: the Atherosclerosis Risk in Communities study." Nephrol Dial Transplant. 2015;30(1):77-83.
"Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study." PLoS One. 2015;10(6):e0128452.
"Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study." Am Heart J. 2015;170(5):961-7.
"sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study." J Diabetes Complications. 2015;29(2):180-5.
"Three-year variability in plasma concentrations of the soluble receptor for advanced glycation end products (sRAGE)." Clin Biochem. 2014;47(1-2):132-4.
"sRAGE and risk of diabetes, cardiovascular disease, and death." Diabetes. 2013;62(6):2116-21.